Belgium (BE)

Technical use of intravascular ultrasound in chronic total occlusion percutaneous coronary interventions: insights from the Euro-CTO registry (2025) Arioti M, Moroni A, Mashayekhi K, Werner GS, Agostoni P, Gorgulu S, Ayoub M, et al. Journal article Polycyclic aromatic hydrocarbon destruction in star-forming regions across 42 nearby galaxies (2025) Egorov OV, Leroy AK, Sandstrom K, Kreckel K, Baron D, Belfiore F, Chown R, et al. Journal article Contact sensitization in children and adolescents: Trends from a multicentre European study (2011–2022) (2025) Mazzetto R, Uter W, Dugonik A, Giménez-Arnau AM, Simon D, Spiewak R, Patruno C, et al. Journal article Pathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function (2025) Asadollahi R, Ahmad A, Boonsawat P, Shahanoor Hinzen J, Lohse M, Bouazza-Arostegui B, Sun S, et al. Journal article An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease (2025) Solitano V, Hanžel J, Ma C, Battat R, Raine T, Siegmund B, Peyrin-Biroulet L, et al. Journal article The Value of Circulating Tumor HPV DNA in Head and Neck Squamous Cell Cancer: A Review † (2025) Dok R, Nuyts S, Lopez F, Bradford C, Forastiere AA, Strojan P, Agaimy A, et al. Journal article, Review article Biphasic inflammation control by fibroblasts enables spinal cord regeneration in zebrafish (2025) John N, Fleming T, Kolb J, Lyraki O, Vásquez Sepúlveda SI, Parmar A, Kim K, et al. Journal article Beyond Common Energy Transfer: Intramolecular Electron Transfer Cascade Controls Triplet Population of a Long-Lived Iron-Anthracene Molecular Dyad (2025) Glaser F, Beneventi GM, Cadranel A, Troian-Gautier L Journal article HBM4EU e-waste study – Occupational exposure assessment to chromium, cadmium, mercury and lead during e-waste recycling (2025) Leese E, Verdonck J, Porras SP, Airaksinen J, Duca RC, Galea KS, Godderis L, et al. Journal article Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis (2025) Ferrante M, Peyrin-Biroulet L, Arkkila P, Armuzzi A, Colombel JF, Danese S, Faggiani R, et al. Journal article